HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
2006
16401	16401 Harvey PD, Reichenberg A, Bowie CR Cognition and aging in psychopathology: Focus on schizophrenia and depression ANNUAL REVIEW OF CLINICAL PSYCHOLOGY. 2006; 2: 389-409	0	4	13	67
16402	16402 Mackay TEC, Anholt RRH Of flies and man: Drosophila as a model for human complex traits ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS. 2006; 7: 339-367	2	20	36	199
16403	16403 Skovronsky DM, Lee VMY, Trojanowskiz JQ Neurodegenerative diseases: New concepts of pathogenesis and their therapeutic implications ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE. 2006; 1 (1): 151-170	54	86	57	124
16404	16404 Carey PR Raman crystallography and other biochemical applications of Raman microscopy ANNUAL REVIEW OF PHYSICAL CHEMISTRY. 2006; 57: 527-554	0	31	2	42
16405	16405 McAllan BM Dasyurid marsupials as models for the physiology of ageing in humans AUSTRALIAN JOURNAL OF ZOOLOGY. 2006; 54 (3): 159-172	1	4	9	129
16406	16406 Amici S, Gorno-Tempini ML, Ogar JM, Dronkers NF, Miller BL An overview on Primary Progressive Aphasia and its variants BEHAVIOURAL NEUROLOGY. 2006; 17 (2): 77-87	3	12	24	64
16407	16407 Hook VYH Neuroproteases in peptide neurotransmission and neurodegenerative diseases - Applications to drug discovery research BIODRUGS. 2006; 20 (2): 105-119	0	4	24	127
16408	16408 Bisaglia M, Schievano E, Caporale A, Peggion E, Mammi S The 11-mer repeats of human alpha-synuclein in vesicle interactions and lipid composition discrimination: A cooperative role BIOPOLYMERS. 2006; 84 (3): 310-316	14	14	13	32
16409	16409 Yasuhara T, Matsukawa N, Yu GL, Xu L, Mays RW, et al. Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury CELL TRANSPLANTATION. 2006; 15 (3): 231-238	7	31	9	42
16410	16410 Soderstrom K, O'Malley J, Steece-Collier K, Kordower JH Neural repair strategies for Parkinson's disease: insights from primate models CELL TRANSPLANTATION. 2006; 15 (3): 251-265	9	20	21	123
#	Date / Author / Journal	LCS	GCS	LCR	CR
16411	16411 Farrington M, Wreghitt TG, Lever AML, Dunnett SB, Rosser AE, et al. Neural transplantation in Huntington's disease: The NEST-UK donor tissue microbiological screening program and review of the literature CELL TRANSPLANTATION. 2006; 15 (4): 279-294	2	6	6	58
16412	16412 Linazasoro G Cell therapy for Parkinson's disease: Only young onset patients allowed? Reflections about the results of recent clinical trials with cell therapy and the progression of Parkinson's disease CELL TRANSPLANTATION. 2006; 15 (6): 463-473	2	8	23	71
16413	16413 Quinn NP On the dyskinesia problem in fetal mesencephalic tissue-engrafted Parkinson's disease patients CELL TRANSPLANTATION. 2006; 15 (6): 555-555	0	3	4	4
16414	16414 Nandoe RDS, Hurtado A, Levi ADO, Grotenhuis A, Oudega M Bone marrow stromal cells for repair of the spinal cord: Towards clinical application CELL TRANSPLANTATION. 2006; 15 (7): 563-577	0	7	7	119
16415	16415 Jain M, Armstrong RJE, Elneil S, Barker RA Transplanted human neural precursor cells migrate widely but show no lesion-specific tropism in the 6-hydroxydopamine rat model of Parkinson's disease CELL TRANSPLANTATION. 2006; 15 (7): 579-593	2	13	11	67
16416	16416 McLeod M, Hong M, Sen A, Sadi D, Ulalia R, et al. Transplantation of bioreactor-produced neural stem cells into the rodent brain CELL TRANSPLANTATION. 2006; 15 (8-9): 689-697	0	8	10	50
16417	16417 Fornai F, Lazzeri G, Di Poggio AB, Soldani P, De Blasi A, et al. Convergent roles of alpha-synuclein, DA metabolism, and the ubiquitin- proteasome system in nigrostriatal toxicity CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY: COCAINE, GHB, AND SUBSTITUTED AMPHETAMINES. 2006; 1074: 84-89	2	5	9	28
16418	16418 Lazzeri G, Lenzi P, Gesi M, Ferrucci M, Fulceri F, et al. InPC12 cells neurotoxicity induced by methamphetamine is related to proteasome inhibition CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY: COCAINE, GHB, AND SUBSTITUTED AMPHETAMINES. 2006; 1074: 174-177	0	5	6	9
16419	16419 Mauceli G, Busceti CI, Pellegrini A, Soldani P, Lenzi P, et al. Overexpression of alpha-synuclein following methamphetamine - Is it good or bad? CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY: COCAINE, GHB, AND SUBSTITUTED AMPHETAMINES. 2006; 1074: 191-197	3	6	15	25
16420	16420 Heinen-Kammerer T, Rulhoff H, Nelles S, Rychlik R Added therapeutic value of memantine in the treatment of moderate to severe Alzheimer's disease CLINICAL DRUG INVESTIGATION. 2006; 26 (6): 303-314	2	4	1	68
#	Date / Author / Journal	LCS	GCS	LCR	CR
16421	16421 Ho L, Qin WP, Stetka BS, Pasinetti GM Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease? CNS DRUGS. 2006; 20 (2): 85-98	2	12	6	96
16422	16422 Marenco S, Weinberger DR Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders CNS DRUGS. 2006; 20 (3): 173-185	1	11	3	101
16423	16423 Williams-Gray CH, Foltynie T, Lewis SJG, Barker RA Cognitive deficits and psychosis in Parkinson's disease - A review of pathophysiology and therapeutic options CNS DRUGS. 2006; 20 (6): 477-505	5	23	16	155
16424	16424 Zafrilla P, Mulero J, Xandri JM, Santo E, Caravaca G, et al. Oxidative stress in Alzheimer patients in different stages of the disease CURRENT MEDICINAL CHEMISTRY. 2006; 13 (9): 1075-1083	3	18	8	61
16425	16425 Hoozemans JJM, Chafekar SM, Baas F, Eikelenboom P, Scheper W Always around, never the same: Pathways of amyloid beta induced neurodegeneration throughout the pathogenic cascade of Alzheimer's disease CURRENT MEDICINAL CHEMISTRY. 2006; 13 (22): 2599-2605	4	12	23	96
16426	16426 Ray SK Currently evaluated calpain and caspase inhibitors for neuroprotection in experimental brain ischemia CURRENT MEDICINAL CHEMISTRY. 2006; 13 (28): 3425-3440	2	16	10	246
16427	16427 Lastres-Becker I, Fernandez-Ruiz J An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatments CURRENT MEDICINAL CHEMISTRY. 2006; 13 (30): 3705-3718	1	11	24	166
16428	16428 D'Andrea MR, Nagele RG Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (6): 677-684	2	43	15	82
16429	16429 Webber KM, Casadesus G, Zhu XW, Obrenovich ME, Atwood CS, et al. The cell cycle and hormonal fluxes in Alzheimer disease: A novel therapeutic target CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (6): 691-697	1	7	20	88
16430	16430 Marklund N, Bakshi A, Castelbuono DJ, Conte V, McIntosh TK Evaluation of pharmacological treatment strategies in traumatic brain injury CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (13): 1645-1680	9	35	119	608
#	Date / Author / Journal	LCS	GCS	LCR	CR
16431	16431 Herbst M, Wanker EE Therapeutic approaches to polyglutamine diseases: Combating protein misfolding and aggregation CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (20): 2543-2555	6	11	42	176
16432	16432 Sigurdsson EM Immunotherapy for conformational diseases CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (20): 2569-2585	7	12	17	222
16433	16433 Gilgun-Sherki Y, Melamed E, Offen D Anti-inflammatory drugs in the treatment of neurodegenerative diseases: Current state CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (27): 3509-3519	1	12	4	146
16434	16434 DaSilva KA, Aubert I, McLaurin J Vaccine development for Alzheimer's disease CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4283-4293	3	8	19	131
16435	16435 Ziani-Cherif C, Mostefa-Kara B, Brixi-Gormat FZ Gamma-secretase as a pharmacological target in Alzheimer disease research: When, why and how? CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4313-4335	1	7	31	229
16436	16436 Leuchtenberger S, Beher D, Weggen S Selective modulation of A beta 42 production in Alzheimer's disease: Non-steroidal anti-inflammatory drugs and beyond CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4337-4355	4	19	14	178
16437	16437 Ono K, Naiki H, Yamada M The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fA beta), as well as destabilize preformed fA beta CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4357-4375	1	14	17	217
16438	16438 Pallas M, Camins A Molecular and biochemical features in Alzheimer's disease CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4389-4408	3	27	52	252
16439	16439 Boudreau RL, Davidson BL RNAi therapy for neurodegenerative diseases CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOL 75. 2006; 75: 73-92	3	10	10	108
16440	16440 Schmidt B, Baumann S, Braun HA, Larbig G Inhibitors and modulators of beta- and gamma-secretase CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (4): 377-392	3	31	4	156
#	Date / Author / Journal	LCS	GCS	LCR	CR
16441	16441 Churcher I Tau therapeutic strategies for the treatment of Alzheimer's disease CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (6): 579-595	28	49	76	178
16442	16442 Sankaranarayanan S Genetically modified mice models for Alzheimer's disease CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (6): 609-627	0	3	55	235
16443	16443 Coimbra A, Williams DS, Hostetler ED The role of MRI and PET/SPECT in Alzheimer's disease CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (6): 629-647	4	13	49	171
16444	16444 Brodsky JL, Chiosis G Hsp70 molecular chaperones: Emerging roles in human disease and identification of small molecule modulators CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (11): 1215-1225	6	67	7	171
16445	16445 Gehrig A, Janssen A, Horling F, Grimm C, Weber BHF The role of caspases in photoreceptor cell death of the retinoschisin- deficient mouse CYTOGENETIC AND GENOME RESEARCH. 2006; 115 (1): 35-44	0	6	3	58
16446	16446 Kowalik-Jankowska T, Rajewska A, Jankowska E, Grzonka Z Copper(II) binding by fragments of alpha-synuclein containing M-1-D-2- and -H-50-residues; a combined potentiometric and spectroscopic study DALTON TRANSACTIONS. 2006; (42): 5068-5076	9	18	24	69
16447	16447 Shinagawa S, Ikeda M, Fukuhara R, Tanabe H Initial symptoms in frontotemporal dementia and semantic dementia compared with Alzheimer's disease DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (2): 74-80	8	16	4	38
16448	16448 Wallin AK, Blennow K, Andreasen N, Minthon L CSF biomarkers for Alzheimer's disease: Levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (3): 131-138	17	30	11	44
16449	16449 Tsai SJ, Hong CJ, Liu HC, Liu TY, Liou YJ The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a Chinese population DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (3): 139-143	6	8	1	29
16450	16450 Liu HC, Hu CJ, Chang JG, Sung SM, Lee LS, et al. Proteomic identification of lower apolipoprotein A-I in Alzheimer's disease DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (3): 155-161	4	16	3	32
#	Date / Author / Journal	LCS	GCS	LCR	CR
16451	16451 Counts SE, Chen EY, Che SL, Ikonomovic MD, Wuu J, et al. Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (4): 205-214	9	14	9	68
16452	16452 Brettschneider J, Petzold A, Schottle D, Claus A, Riepe M, et al. The neurofilament heavy chain (NfH(SMI35)) in the cerebrospinal fluid diagnosis of Alzheimer's disease DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (5-6): 291-295	6	14	15	32
16453	16453 Bocti C, Rockel C, Roy P, Gao FQ, Black SE Topographical patterns of lobar atrophy in frontotemporal dementia and Alzheimer's disease DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (5-6): 364-372	9	13	7	51
16454	16454 Peters F, Perani D, Herholz K, Holthoff V, Beuthien-Baumann B, et al. Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (5-6): 373-379	13	34	4	36
16455	16455 Hodges JR, Erzinclioglu S, Patterson K Evolution of cognitive deficits and conversion to dementia in patients with mild cognitive impairment: A very-long-term follow-up study DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (5-6): 380-391	6	37	2	47
16456	16456 Castiglioni S, Pelati O, Zuffi M, Somalvico F, Marino L, et al. The Frontal Assessment Battery does not differentiate frontotemporal dementia from Alzheimer's disease DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (2): 125-131	2	13	7	34
16457	16457 Chow TW, Hynan LS, Lipton AM MMSE scores decline at a greater rate in frontotemporal degeneration than in AD DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (3): 194-199	7	12	8	36
16458	16458 Mollenhauer B, Trenkwalder C, von Ahsen N, Bibl M, Steinacker P, et al. Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (3): 200-208	15	28	22	60
16459	16459 Ross ED, Shah SN, Prodan CI, Monnot M Changing relative prevalence of Alzheimer disease versus non-Alzheimer disease dementias: Have we underestimated the looming dementia epidemic? DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (4): 273-277	1	4	8	26
16460	16460 Perry RJ, Graham A, Williams G, Rosen H, Erzinclioglu S, et al. Patterns of frontal lobe atrophy in frontotemporal dementia: A volumetric MRI study DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (4): 278-287	9	22	5	37
#	Date / Author / Journal	LCS	GCS	LCR	CR
16461	16461 Kurz MW, Schlitter AM, Larsen JP, Ballard C, Aarsland D Familial occurrence of dementia and parkinsonism - A systematic review DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (4): 288-295	5	7	34	67
16462	16462 Diehl-Schmid J, Grimmer T, Drzezga A, Bornschein S, Perneczky R, et al. Longitudinal changes of cerebral glucose metabolism in semantic dementia DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (4): 346-351	4	8	6	28
16463	16463 Hanyu H, Shimizu S, Hirao K, Sakurai H, Iwamoto T, et al. The role of I-123-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (5-6): 379-384	9	13	6	37
16464	16464 Giza CC, Prins ML Is being plastic fantastic? Mechanisms of altered plasticity after developmental traumatic brain injury DEVELOPMENTAL NEUROSCIENCE. 2006; 28 (4-5): 364-379	3	17	14	102
16465	16465 Pullela R, Raber J, Pfankuch T, Ferriero DM, Claus CP, et al. Traumatic injury to the immature brain results in progressive neuronal loss, hyperactivity and delayed cognitive impairments DEVELOPMENTAL NEUROSCIENCE. 2006; 28 (4-5): 396-409	7	26	14	68
16466	16466 Kochanek AR, Kline AE, Gao WM, Chadha M, Lai YC, et al. Gel-based hippocampal proteomic analysis 2 weeks following traumatic brain injury to immature rats using controlled cortical impact DEVELOPMENTAL NEUROSCIENCE. 2006; 28 (4-5): 410-419	1	15	4	38
16467	16467 Huh JW, Franklin MA, Widing AG, Raghupathi R Regionally distinct patterns of calpain activation and traumatic axonal injury following contusive brain injury in immature rats DEVELOPMENTAL NEUROSCIENCE. 2006; 28 (4-5): 466-476	4	7	12	36
16468	16468 Fonteh AN, Harrington RJ, Huhmer AF, Biringer RG, Riggins JN, et al. Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods DISEASE MARKERS. 2006; 22 (1-2): 39-64	2	25	8	238
16469	16469 Rongve A, Aarsland D Management of Parkinson's disease dementia - Practical considerations DRUGS & AGING. 2006; 23 (10): 807-822	1	5	30	141
16470	16470 Crino PB Focal malformations of cortical development: Epilepsy, autism, and dyslexia DYSLEXIC BRAIN. 2006; : 195-208	0	0	7	63
#	Date / Author / Journal	LCS	GCS	LCR	CR
16471	16471 Xu HX, Wang RS, Zhang YW, Zhang X Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease ESTROGENS AND HUMAN DISEASES. 2006; 1089: 324-342	2	20	4	66
16472	16472 Candore G, Balistreri CR, Grimaldi MP, Vasto S, Listi F, et al. Age-related inflammatory diseases - Role of genetics and gender in the pathophysiology of Alzheimer's disease ESTROGENS AND HUMAN DISEASES. 2006; 1089: 472-486	2	13	7	96
16473	16473 Armstrong RA Plaques and tangles and the pathogenesis of Alzheimer's disease FOLIA NEUROPATHOLOGICA. 2006; 44 (1): 1-11	4	23	31	88
16474	16474 Saarela MS, Lehtimaki T, Rinne JO, Huhtala H, Rontu R, et al. No association between the brain-derived neurotrophic factor 196G > A or 270C > T polymorphisms and Alzheimer's or Parkinson's disease FOLIA NEUROPATHOLOGICA. 2006; 44 (1): 12-16	5	10	3	31
16475	16475 Rafalowska J, Fidzianska A, Dziewulska D, Gadamski R, Ogonowska W, et al. Progression of morphological changes within CNS in a transgenic rat model of familial amyotrophic lateral sclerosis FOLIA NEUROPATHOLOGICA. 2006; 44 (3): 162-174	2	8	16	41
16476	16476 Klodowska-Duda G, Slowinski J, Opala G, Gorzkowska A, Jasinska-Myga B, et al. Corticobasal degeneration - clinico-pathological considerations FOLIA NEUROPATHOLOGICA. 2006; 44 (4): 257-264	1	3	8	25
16477	16477 Ginsberg SD, Mirnics K Functional genomic methodologies FUNCTIONAL GENOMICS AND PROTEOMICS IN THE CLINICAL NEUROSCIENCES. 2006; 158: 15-40	3	6	43	201
16478	16478 Hemby SE Assessment of genome and proteome profiles in cocaine abuse FUNCTIONAL GENOMICS AND PROTEOMICS IN THE CLINICAL NEUROSCIENCES. 2006; 158: 173-195	1	14	10	85
16479	16479 Mufson EJ, Counts SE, Che SL, Ginsberg SD Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease FUNCTIONAL GENOMICS AND PROTEOMICS IN THE CLINICAL NEUROSCIENCES. 2006; 158: 197-222	5	15	53	141
16480	16480 Binder EB, Nemeroff CB Implications for the practice of psychiatry FUNCTIONAL GENOMICS AND PROTEOMICS IN THE CLINICAL NEUROSCIENCES. 2006; 158: 275-293	0	0	15	122
#	Date / Author / Journal	LCS	GCS	LCR	CR
16481	16481 van Belzen MJ, Heutink P Genetic analysis of psychiatric disorders in humans GENES BRAIN AND BEHAVIOR. 2006; 5: 25-33	0	1	2	80
16482	16482 Grazina M, Pratas J, Silva F, Oliveira S, Santana I, et al. Genetic basis of Alzheimer's dementia: role of mtDNA mutations GENES BRAIN AND BEHAVIOR. 2006; 5: 92-107	0	4	27	183
16483	16483 Pham TQ, Kifley A, Mitchell P, Wang JJ Relation of age-related macular degeneration and cognitive impairment in an older population GERONTOLOGY. 2006; 52 (6): 353-358	2	7	2	30
16484	16484 Moskal JR, Kroes RA, Otto NJ, Rahimi O, Claiborne BJ Distinct patterns of gene expression in the left and right hippocampal formation of developing HIPPOCAMPUS. 2006; 16 (8): 629-634	0	6	1	29
16485	16485 Eastwood SL, Weickert CS, Webster MJ, Herman MM, Kleinman JE, et al. Synaptophysin protein and mRNA expression in the human hippocampal formation from birth to old age HIPPOCAMPUS. 2006; 16 (8): 645-654	1	9	20	103
16486	16486 Gogtay N, Nugent TF, Herman DH, Ordonez A, Greenstein D, et al. Dynamic mapping of normal human hippocampal development HIPPOCAMPUS. 2006; 16 (8): 664-672	4	48	8	68
16487	16487 Joelving FC, Billeskov R, Christensen JR, West M, Pakkenberg B Hippocampal neuron and glial cell numbers in Parkinson's disease - A stereological study HIPPOCAMPUS. 2006; 16 (10): 826-833	1	9	6	41
16488	16488 Kim YJ, Takahashi R Role of polyunsaturated fatty acids for misfolding protein aggregations - Implication for neurodegenerative diseases INTEGRATED MOLECULAR MEDICINE FOR NEURONAL AND NEOPLASTIC DISORDERS. 2006; 1086: 11-20	0	7	14	58
16489	16489 Bailey JA, Lahiri DK Neuronal differentiation is accompanied by increased levels of SNAP-25 protein in fetal rat primary cortical neurons - Implications in neuronal plasticity and Alzheimer's disease INTEGRATED MOLECULAR MEDICINE FOR NEURONAL AND NEOPLASTIC DISORDERS. 2006; 1086: 54-65	1	6	6	27
16490	16490 Mendez MF The accurate diagnosis of early-onset dementia INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE. 2006; 36 (4): 401-412	2	17	9	50
#	Date / Author / Journal	LCS	GCS	LCR	CR
16491	16491 Guzhova I, Margulis B Hsp70 chaperone as a survival factor in cell pathology INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 254. 2006; 254: 101-149	0	21	20	226
16492	16492 Dillen K, Annaert W A two decade contribution of molecular cell biology to the centennial of Alzheimer's disease: Are we progressing toward therapy? INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 254. 2006; 254: 215-300	3	11	52	534
16493	16493 Keller JN Interplay between oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 12129	0	0	6	20
16494	16494 Takeda A, Hasegawa T, Matsuzaki-Kobayashi M, Sugeno N, Kikuchi A, et al. Mechanisms of neuronal death in synucleinopathy JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 19365	0	10	26	39
16495	16495 Reddy PH Mitochondrial oxidative damage in aging and Alzheimer's disease: Implications for mitochondrially targeted antioxidant therapeutics JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 31372	0	26	25	127
16496	16496 Gong CX, Liu F, Grundke-Iqbal I, Iqbal K Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: A therapeutic target JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 31825	0	16	98	159
16497	16497 Casadesus G, Puig ER, Webber KM, Atwood CS, Escuer MC, et al. Targeting gonadotropins: An alternative option for Alzheimer disease treatment JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 39508	0	2	27	128
16498	16498 Avila J, Santa-Maria I, Perez M, Hernandez F, Moreno F Tau phosphorylation, aggregation, and cell toxicity JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 74539	0	9	35	57
16499	16499 Hruska KS, Goker-Alpan O, Sidransky E Gaucher disease and the synucleinopathies JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 78549	0	12	12	38
16500	16500 Nunomura A, Honda K, Takeda A, Hirai K, Zhu XW, et al. Oxidative damage to RNA in neurodegenerative diseases JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 82323	0	18	8	46

Date / Author / Journal

LCS

GCS

LCR

2006

16401

16401 Harvey PD, Reichenberg A, Bowie CR

Cognition and aging in psychopathology: Focus on schizophrenia and depression

ANNUAL REVIEW OF CLINICAL PSYCHOLOGY. 2006; 2: 389-409

16402

16402 Mackay TEC, Anholt RRH

Of flies and man: Drosophila as a model for human complex traits

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS. 2006; 7: 339-367

199

16403

16403 Skovronsky DM, Lee VMY, Trojanowskiz JQ

Neurodegenerative diseases: New concepts of pathogenesis and their therapeutic implications

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE. 2006; 1 (1): 151-170

124

16404

16404 Carey PR

Raman crystallography and other biochemical applications of Raman microscopy

ANNUAL REVIEW OF PHYSICAL CHEMISTRY. 2006; 57: 527-554

16405

16405 McAllan BM

Dasyurid marsupials as models for the physiology of ageing in humans

AUSTRALIAN JOURNAL OF ZOOLOGY. 2006; 54 (3): 159-172

129

16406

16406 Amici S, Gorno-Tempini ML, Ogar JM, Dronkers NF, Miller BL

An overview on Primary Progressive Aphasia and its variants

BEHAVIOURAL NEUROLOGY. 2006; 17 (2): 77-87

16407

16407 Hook VYH

Neuroproteases in peptide neurotransmission and neurodegenerative diseases - Applications to drug discovery research

BIODRUGS. 2006; 20 (2): 105-119

127

16408

16408 Bisaglia M, Schievano E, Caporale A, Peggion E, Mammi S

The 11-mer repeats of human alpha-synuclein in vesicle interactions and lipid composition discrimination: A cooperative role

BIOPOLYMERS. 2006; 84 (3): 310-316

16409

16409 Yasuhara T, Matsukawa N, Yu GL, Xu L, Mays RW, et al.

Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury

CELL TRANSPLANTATION. 2006; 15 (3): 231-238

16410

16410 Soderstrom K, O'Malley J, Steece-Collier K, Kordower JH

Neural repair strategies for Parkinson's disease: insights from primate models

CELL TRANSPLANTATION. 2006; 15 (3): 251-265

123

Date / Author / Journal

LCS

GCS

LCR

16411

16411 Farrington M, Wreghitt TG, Lever AML, Dunnett SB, Rosser AE, et al.

Neural transplantation in Huntington's disease: The NEST-UK donor tissue microbiological screening program and review of the literature

CELL TRANSPLANTATION. 2006; 15 (4): 279-294

16412

16412 Linazasoro G

Cell therapy for Parkinson's disease: Only young onset patients allowed? Reflections about the results of recent clinical trials with cell therapy and the progression of Parkinson's disease

CELL TRANSPLANTATION. 2006; 15 (6): 463-473

16413

16413 Quinn NP

On the dyskinesia problem in fetal mesencephalic tissue-engrafted Parkinson's disease patients

CELL TRANSPLANTATION. 2006; 15 (6): 555-555

16414

16414 Nandoe RDS, Hurtado A, Levi ADO, Grotenhuis A, Oudega M

Bone marrow stromal cells for repair of the spinal cord: Towards clinical application

CELL TRANSPLANTATION. 2006; 15 (7): 563-577

119

16415

16415 Jain M, Armstrong RJE, Elneil S, Barker RA

Transplanted human neural precursor cells migrate widely but show no lesion-specific tropism in the 6-hydroxydopamine rat model of Parkinson's disease

CELL TRANSPLANTATION. 2006; 15 (7): 579-593

16416

16416 McLeod M, Hong M, Sen A, Sadi D, Ulalia R, et al.

Transplantation of bioreactor-produced neural stem cells into the rodent brain

CELL TRANSPLANTATION. 2006; 15 (8-9): 689-697

16417

16417 Fornai F, Lazzeri G, Di Poggio AB, Soldani P, De Blasi A, et al.

Convergent roles of alpha-synuclein, DA metabolism, and the ubiquitin- proteasome system in nigrostriatal toxicity

CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY: COCAINE, GHB, AND SUBSTITUTED AMPHETAMINES. 2006; 1074: 84-89

16418

16418 Lazzeri G, Lenzi P, Gesi M, Ferrucci M, Fulceri F, et al.

InPC12 cells neurotoxicity induced by methamphetamine is related to proteasome inhibition

CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY: COCAINE, GHB, AND SUBSTITUTED AMPHETAMINES. 2006; 1074: 174-177

16419

16419 Mauceli G, Busceti CI, Pellegrini A, Soldani P, Lenzi P, et al.

Overexpression of alpha-synuclein following methamphetamine - Is it good or bad?

CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY: COCAINE, GHB, AND SUBSTITUTED AMPHETAMINES. 2006; 1074: 191-197

16420

16420 Heinen-Kammerer T, Rulhoff H, Nelles S, Rychlik R

Added therapeutic value of memantine in the treatment of moderate to severe Alzheimer's disease

CLINICAL DRUG INVESTIGATION. 2006; 26 (6): 303-314

Date / Author / Journal

LCS

GCS

LCR

16421

16421 Ho L, Qin WP, Stetka BS, Pasinetti GM

Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease?

CNS DRUGS. 2006; 20 (2): 85-98

16422

16422 Marenco S, Weinberger DR

Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders

CNS DRUGS. 2006; 20 (3): 173-185

101

16423

16423 Williams-Gray CH, Foltynie T, Lewis SJG, Barker RA

Cognitive deficits and psychosis in Parkinson's disease - A review of pathophysiology and therapeutic options

CNS DRUGS. 2006; 20 (6): 477-505

155

16424

16424 Zafrilla P, Mulero J, Xandri JM, Santo E, Caravaca G, et al.

Oxidative stress in Alzheimer patients in different stages of the disease

CURRENT MEDICINAL CHEMISTRY. 2006; 13 (9): 1075-1083

16425

16425 Hoozemans JJM, Chafekar SM, Baas F, Eikelenboom P, Scheper W

Always around, never the same: Pathways of amyloid beta induced neurodegeneration throughout the pathogenic cascade of Alzheimer's disease

CURRENT MEDICINAL CHEMISTRY. 2006; 13 (22): 2599-2605

16426

16426 Ray SK

Currently evaluated calpain and caspase inhibitors for neuroprotection in experimental brain ischemia

CURRENT MEDICINAL CHEMISTRY. 2006; 13 (28): 3425-3440

246

16427

16427 Lastres-Becker I, Fernandez-Ruiz J

An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatments

CURRENT MEDICINAL CHEMISTRY. 2006; 13 (30): 3705-3718

166

16428

16428 D'Andrea MR, Nagele RG

Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (6): 677-684

16429

16429 Webber KM, Casadesus G, Zhu XW, Obrenovich ME, Atwood CS, et al.

The cell cycle and hormonal fluxes in Alzheimer disease: A novel therapeutic target

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (6): 691-697

16430

16430 Marklund N, Bakshi A, Castelbuono DJ, Conte V, McIntosh TK

Evaluation of pharmacological treatment strategies in traumatic brain injury

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (13): 1645-1680

119

608

Date / Author / Journal

LCS

GCS

LCR

16431

16431 Herbst M, Wanker EE

Therapeutic approaches to polyglutamine diseases: Combating protein misfolding and aggregation

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (20): 2543-2555

176

16432

16432 Sigurdsson EM

Immunotherapy for conformational diseases

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (20): 2569-2585

222

16433

16433 Gilgun-Sherki Y, Melamed E, Offen D

Anti-inflammatory drugs in the treatment of neurodegenerative diseases: Current state

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (27): 3509-3519

146

16434

16434 DaSilva KA, Aubert I, McLaurin J

Vaccine development for Alzheimer's disease

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4283-4293

131

16435

16435 Ziani-Cherif C, Mostefa-Kara B, Brixi-Gormat FZ

Gamma-secretase as a pharmacological target in Alzheimer disease research: When, why and how?

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4313-4335

229

16436

16436 Leuchtenberger S, Beher D, Weggen S

Selective modulation of A beta 42 production in Alzheimer's disease: Non-steroidal anti-inflammatory drugs and beyond

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4337-4355

178

16437

16437 Ono K, Naiki H, Yamada M

The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fA beta), as well as destabilize preformed fA beta

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4357-4375

217

16438

16438 Pallas M, Camins A

Molecular and biochemical features in Alzheimer's disease

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4389-4408

252

16439

16439 Boudreau RL, Davidson BL

RNAi therapy for neurodegenerative diseases

CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOL 75. 2006; 75: 73-92

108

16440

16440 Schmidt B, Baumann S, Braun HA, Larbig G

Inhibitors and modulators of beta- and gamma-secretase

CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (4): 377-392

156

Date / Author / Journal

16441

Tau therapeutic strategies for the treatment of Alzheimer's disease

CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (6): 579-595

178

16442

16442 Sankaranarayanan S

Genetically modified mice models for Alzheimer's disease

CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (6): 609-627

235

16443

16443 Coimbra A, Williams DS, Hostetler ED

The role of MRI and PET/SPECT in Alzheimer's disease

CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (6): 629-647

171

16444

16444 Brodsky JL, Chiosis G

Hsp70 molecular chaperones: Emerging roles in human disease and identification of small molecule modulators

CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (11): 1215-1225

171

16445

16445 Gehrig A, Janssen A, Horling F, Grimm C, Weber BHF

The role of caspases in photoreceptor cell death of the retinoschisin- deficient mouse

CYTOGENETIC AND GENOME RESEARCH. 2006; 115 (1): 35-44

16446

16446 Kowalik-Jankowska T, Rajewska A, Jankowska E, Grzonka Z

Copper(II) binding by fragments of alpha-synuclein containing M-1-D-2- and -H-50-residues; a combined potentiometric and spectroscopic study

DALTON TRANSACTIONS. 2006; (42): 5068-5076

16447

16447 Shinagawa S, Ikeda M, Fukuhara R, Tanabe H

Initial symptoms in frontotemporal dementia and semantic dementia compared with Alzheimer's disease

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (2): 74-80

16448

16448 Wallin AK, Blennow K, Andreasen N, Minthon L

CSF biomarkers for Alzheimer's disease: Levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (3): 131-138

16449

16449 Tsai SJ, Hong CJ, Liu HC, Liu TY, Liou YJ

The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a Chinese population

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (3): 139-143

16450

16450 Liu HC, Hu CJ, Chang JG, Sung SM, Lee LS, et al.

Proteomic identification of lower apolipoprotein A-I in Alzheimer's disease

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (3): 155-161

Date / Author / Journal

LCS

GCS

LCR

16451

16451 Counts SE, Chen EY, Che SL, Ikonomovic MD, Wuu J, et al.

Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (4): 205-214

16452

16452 Brettschneider J, Petzold A, Schottle D, Claus A, Riepe M, et al.

The neurofilament heavy chain (NfH(SMI35)) in the cerebrospinal fluid diagnosis of Alzheimer's disease

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (5-6): 291-295

16453

16453 Bocti C, Rockel C, Roy P, Gao FQ, Black SE

Topographical patterns of lobar atrophy in frontotemporal dementia and Alzheimer's disease

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (5-6): 364-372

16454

16454 Peters F, Perani D, Herholz K, Holthoff V, Beuthien-Baumann B, et al.

Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (5-6): 373-379

16455

16455 Hodges JR, Erzinclioglu S, Patterson K

Evolution of cognitive deficits and conversion to dementia in patients with mild cognitive impairment: A very-long-term follow-up study

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 21 (5-6): 380-391

16456

16456 Castiglioni S, Pelati O, Zuffi M, Somalvico F, Marino L, et al.

The Frontal Assessment Battery does not differentiate frontotemporal dementia from Alzheimer's disease

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (2): 125-131

16457

16457 Chow TW, Hynan LS, Lipton AM

MMSE scores decline at a greater rate in frontotemporal degeneration than in AD

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (3): 194-199

16458

16458 Mollenhauer B, Trenkwalder C, von Ahsen N, Bibl M, Steinacker P, et al.

Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (3): 200-208

16459

16459 Ross ED, Shah SN, Prodan CI, Monnot M

Changing relative prevalence of Alzheimer disease versus non-Alzheimer disease dementias: Have we underestimated the looming dementia epidemic?

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (4): 273-277

16460

16460 Perry RJ, Graham A, Williams G, Rosen H, Erzinclioglu S, et al.

Patterns of frontal lobe atrophy in frontotemporal dementia: A volumetric MRI study

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (4): 278-287

Date / Author / Journal

LCS

GCS

LCR

16461

16461 Kurz MW, Schlitter AM, Larsen JP, Ballard C, Aarsland D

Familial occurrence of dementia and parkinsonism - A systematic review

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (4): 288-295

16462

16462 Diehl-Schmid J, Grimmer T, Drzezga A, Bornschein S, Perneczky R, et al.

Longitudinal changes of cerebral glucose metabolism in semantic dementia

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (4): 346-351

16463

16463 Hanyu H, Shimizu S, Hirao K, Sakurai H, Iwamoto T, et al.

The role of I-123-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (5-6): 379-384

16464

16464 Giza CC, Prins ML

Is being plastic fantastic? Mechanisms of altered plasticity after developmental traumatic brain injury

DEVELOPMENTAL NEUROSCIENCE. 2006; 28 (4-5): 364-379

102

16465

16465 Pullela R, Raber J, Pfankuch T, Ferriero DM, Claus CP, et al.

Traumatic injury to the immature brain results in progressive neuronal loss, hyperactivity and delayed cognitive impairments

DEVELOPMENTAL NEUROSCIENCE. 2006; 28 (4-5): 396-409

16466

16466 Kochanek AR, Kline AE, Gao WM, Chadha M, Lai YC, et al.

Gel-based hippocampal proteomic analysis 2 weeks following traumatic brain injury to immature rats using controlled cortical impact

DEVELOPMENTAL NEUROSCIENCE. 2006; 28 (4-5): 410-419

16467

16467 Huh JW, Franklin MA, Widing AG, Raghupathi R

Regionally distinct patterns of calpain activation and traumatic axonal injury following contusive brain injury in immature rats

DEVELOPMENTAL NEUROSCIENCE. 2006; 28 (4-5): 466-476

16468

16468 Fonteh AN, Harrington RJ, Huhmer AF, Biringer RG, Riggins JN, et al.

Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods

DISEASE MARKERS. 2006; 22 (1-2): 39-64

238

16469

16469 Rongve A, Aarsland D

Management of Parkinson's disease dementia - Practical considerations

DRUGS & AGING. 2006; 23 (10): 807-822

141

16470

16470 Crino PB

Focal malformations of cortical development: Epilepsy, autism, and dyslexia

DYSLEXIC BRAIN. 2006; : 195-208

Date / Author / Journal

LCS

GCS

LCR

16471

16471 Xu HX, Wang RS, Zhang YW, Zhang X

Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease

ESTROGENS AND HUMAN DISEASES. 2006; 1089: 324-342

16472

16472 Candore G, Balistreri CR, Grimaldi MP, Vasto S, Listi F, et al.

ESTROGENS AND HUMAN DISEASES. 2006; 1089: 472-486

16473

16473 Armstrong RA

Plaques and tangles and the pathogenesis of Alzheimer's disease

FOLIA NEUROPATHOLOGICA. 2006; 44 (1): 1-11

16474

16474 Saarela MS, Lehtimaki T, Rinne JO, Huhtala H, Rontu R, et al.

No association between the brain-derived neurotrophic factor 196G > A or 270C > T polymorphisms and Alzheimer's or Parkinson's disease

FOLIA NEUROPATHOLOGICA. 2006; 44 (1): 12-16

16475

16475 Rafalowska J, Fidzianska A, Dziewulska D, Gadamski R, Ogonowska W, et al.

Progression of morphological changes within CNS in a transgenic rat model of familial amyotrophic lateral sclerosis

FOLIA NEUROPATHOLOGICA. 2006; 44 (3): 162-174

16476

16476 Klodowska-Duda G, Slowinski J, Opala G, Gorzkowska A, Jasinska-Myga B, et al.

Corticobasal degeneration - clinico-pathological considerations

FOLIA NEUROPATHOLOGICA. 2006; 44 (4): 257-264

16477

16477 Ginsberg SD, Mirnics K

Functional genomic methodologies

FUNCTIONAL GENOMICS AND PROTEOMICS IN THE CLINICAL NEUROSCIENCES. 2006; 158: 15-40

201

16478

16478 Hemby SE

Assessment of genome and proteome profiles in cocaine abuse

FUNCTIONAL GENOMICS AND PROTEOMICS IN THE CLINICAL NEUROSCIENCES. 2006; 158: 173-195

16479

16479 Mufson EJ, Counts SE, Che SL, Ginsberg SD

Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease

FUNCTIONAL GENOMICS AND PROTEOMICS IN THE CLINICAL NEUROSCIENCES. 2006; 158: 197-222

141

16480

16480 Binder EB, Nemeroff CB

Implications for the practice of psychiatry

FUNCTIONAL GENOMICS AND PROTEOMICS IN THE CLINICAL NEUROSCIENCES. 2006; 158: 275-293

122

Date / Author / Journal

LCS

GCS

LCR

16481

16481 van Belzen MJ, Heutink P

Genetic analysis of psychiatric disorders in humans

GENES BRAIN AND BEHAVIOR. 2006; 5: 25-33

16482

16482 Grazina M, Pratas J, Silva F, Oliveira S, Santana I, et al.

Genetic basis of Alzheimer's dementia: role of mtDNA mutations

GENES BRAIN AND BEHAVIOR. 2006; 5: 92-107

183

16483

16483 Pham TQ, Kifley A, Mitchell P, Wang JJ

Relation of age-related macular degeneration and cognitive impairment in an older population

GERONTOLOGY. 2006; 52 (6): 353-358

16484

16484 Moskal JR, Kroes RA, Otto NJ, Rahimi O, Claiborne BJ

Distinct patterns of gene expression in the left and right hippocampal formation of developing

HIPPOCAMPUS. 2006; 16 (8): 629-634

16485

16485 Eastwood SL, Weickert CS, Webster MJ, Herman MM, Kleinman JE, et al.

Synaptophysin protein and mRNA expression in the human hippocampal formation from birth to old age

HIPPOCAMPUS. 2006; 16 (8): 645-654

103

16486

16486 Gogtay N, Nugent TF, Herman DH, Ordonez A, Greenstein D, et al.

Dynamic mapping of normal human hippocampal development

HIPPOCAMPUS. 2006; 16 (8): 664-672

16487

16487 Joelving FC, Billeskov R, Christensen JR, West M, Pakkenberg B

Hippocampal neuron and glial cell numbers in Parkinson's disease - A stereological study

HIPPOCAMPUS. 2006; 16 (10): 826-833

16488

16488 Kim YJ, Takahashi R

Role of polyunsaturated fatty acids for misfolding protein aggregations - Implication for neurodegenerative diseases

INTEGRATED MOLECULAR MEDICINE FOR NEURONAL AND NEOPLASTIC DISORDERS. 2006; 1086: 11-20

16489

16489 Bailey JA, Lahiri DK

Neuronal differentiation is accompanied by increased levels of SNAP-25 protein in fetal rat primary cortical neurons - Implications in neuronal plasticity and Alzheimer's disease

INTEGRATED MOLECULAR MEDICINE FOR NEURONAL AND NEOPLASTIC DISORDERS. 2006; 1086: 54-65

16490

16490 Mendez MF

The accurate diagnosis of early-onset dementia

INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE. 2006; 36 (4): 401-412

Date / Author / Journal

LCS

GCS

LCR

16491

16491 Guzhova I, Margulis B

Hsp70 chaperone as a survival factor in cell pathology

INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 254. 2006; 254: 101-149

226

16492

16492 Dillen K, Annaert W

A two decade contribution of molecular cell biology to the centennial of Alzheimer's disease: Are we progressing toward therapy?

INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 254. 2006; 254: 215-300

534

16493

16493 Keller JN

Interplay between oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 12129

16494

16494 Takeda A, Hasegawa T, Matsuzaki-Kobayashi M, Sugeno N, Kikuchi A, et al.

Mechanisms of neuronal death in synucleinopathy

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 19365

16495

16495 Reddy PH

Mitochondrial oxidative damage in aging and Alzheimer's disease: Implications for mitochondrially targeted antioxidant therapeutics

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 31372

127

16496

16496 Gong CX, Liu F, Grundke-Iqbal I, Iqbal K

Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: A therapeutic target

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 31825

159

16497

16497 Casadesus G, Puig ER, Webber KM, Atwood CS, Escuer MC, et al.

Targeting gonadotropins: An alternative option for Alzheimer disease treatment

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 39508

128

16498

16498 Avila J, Santa-Maria I, Perez M, Hernandez F, Moreno F

Tau phosphorylation, aggregation, and cell toxicity

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 74539

16499

16499 Hruska KS, Goker-Alpan O, Sidransky E

Gaucher disease and the synucleinopathies

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 78549

16500

16500 Nunomura A, Honda K, Takeda A, Hirai K, Zhu XW, et al.

Oxidative damage to RNA in neurodegenerative diseases

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 82323

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records